��躰�肽𨯙嚙踝蕭�椬��㮖����𠺪蕭��辷蕭
��躰�頣蕭皛抵�䈑蕭嚙踝蕭膌见�躰�肽𨯙
��躰�肽𨯙嚙踝蕭颲瑁𨯙�𢥫嚙質�嚙踢�𧶏蕭薳��𨯙
��躰釭嚙賢��𨯙嚙賡ㄤ��躰釭嚙賭�對蕭嚙�
��躰釭嚙賢��𨯙嚙踝蕭蒺矋蕭嚙賣���辷蕭
��躰�頣蕭嚙質𨯙��鞱�矋蕭��躰�肽𨯙嚙踢岡芾働嚙�
��躰�頣蕭皛抵�䈑蕭嚙踝蕭嚙賢�磰𨯙嚙踢﹜���躰�肽𨯙��躰�肽𨯙
嚙賭麩��躰�肽𨯙嚙賭�𡑒𨯙��躰�肽𨯙��躰�肽𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踝蕭��躰�頣蕭�迚�𨯙
��躰�肽𨯙嚙踝蕭嚙踢�佅嚙賢�躰�肽𨯙嚙踝蕭�迚�𨯙
��躰�肽𨯙嚙賜�嚙踝蕭臐�鳴蕭�莎蕭撠𩤃蕭臐�航𨯙��躰郭嚙踢岸��𨯙��辷蕭
��躰�肽𨯙��躰�肽𨯙嚙賡做嚙踢╱ｇ蕭暻芸�躰腺�𧊋臐�航𨯙��躰�肽𨯙
嚙踝蕭��嚙質�磰𨯙��躰�肽𨯙嚙賢䐓��躰釭臐�嚙踝蕭嚙踝蕭��辷蕭
��躰釭嚙賢��𨯙嚙踢�鍦�躰�栶�笔�辷蕭
��躰都嚙賢�躰腺嚙賬���躰腺嚙賢��
��躰酗��𥕦�躰郭��嚙賢��𨯙��鮋ㄙ
��躰都嚙賢�躰腺嚙賬���躰�肽𨯙��躰�肽𨯙��辷蕭
��躰都嚙賢�躰腺嚙賬�嚙踝蕭嚙質𨯙��躰�肽𨯙
��躰酗藆�坿���嚙質�𨅯�𡑒��𨯙��辷蕭
��躰酗��𨥈蕭嚙踢�航𨯙嚙踝蕭嚙踝蕭臐��𨯙
嚙踢坎萘���朞𨯙�坾蝞�嚙賢�躰�肽𨯙��辷蕭
��躰閉瘣賢�躰酗嚙踢�航𨯙�����𨯙��辷蕭
嚙踢△�嚙踝蕭嚙質𨯙嚙踝蕭璇寡𨯙��辷蕭
��躰�肽𨯙��躰腺銝滚��𨯙��躰�肽𨯙��躰�肽𨯙
��躰�肽𨯙��𥕦�页蕭���𧒆䕘蕭薴ㄟ��躰腺��舘�舘𨯙
��躰腺鈭�䁥滩𨯙嚙賡�嚙踢�𦴣��躰�肽𨯙��躰�肽𨯙
��躰閉�蕟��躰�肽𨯙��嚙踝蕭�𨯙��琜蕭藃�讛𨯙��辷蕭
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰�肽𨯙��躰�肽𨯙
嚙踝蕭薳閦�𥕦�𩤃蕭嚙質𨯙��躰部薴钟��辷蕭
��躰腺嚙賣�坿𨯙��嚙賣Ⅰ�𨯙��躰�肽𨯙��辷蕭
��躰腺嚙賣�坿𨯙��嚙賜�橘蕭嚙質�芷礆嚙�
嚙踝蕭臐号艟洽嚙踝蕭��磰𨯙��躰�肽𨯙��辷蕭
��躰�肽𨯙嚙賢𠘕嚙賢𠹭��㚁蕭銧游�辷蕭
��躰�肽𨯙��𥟇䠋�𨯙��躰�肽𨯙��𥪮�航𨯙
嚙踝蕭�緾嚙賢�躰郭嚙賭�𡑒𨯙嚙踝蕭嚙�
��躰�肽𨯙嚙踢╱Ｚ躀臐��𨯙��躰�肽𨯙��辷蕭
嚙踝蕭艟妟��𥕦�躰郭嚙賭�𤏸𨯙��躰�肽𨯙��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭嚙踝蕭�佞𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭擗�𠯫�𧒆��辷蕭
嚙踝蕭嚙質𨯙�𩸭嚙踢﹛痹蕭�𩣪嚙賣䠋�𨯙嚙踝蕭憍辷蕭�莎蕭嚙質鷄嚙踝蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜脩腦嚙踢𧒆��辷蕭
��躰�肽𨯙��𥕦��𨯙嚙賜�皜賂蕭�樹𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰釭蝮�蕭�𧒆��辷蕭
嚙踝蕭艟妟��𥕦�躰釭�𡁜�躰腺嚙踝蕭藂��𨯙��躰郭嚙賜�樹𧒆��辷蕭
��躰腺�亙�滩𨯙��躰�頣蕭��𡏭𨯙��躰�肽𨯙�����痹蕭嚙�
��躰�肽𨯙嚙踢𧒆䕘蕭嚙踢孜讛𨯙��躰�肽𨯙��辷蕭
嚙踝蕭���蕭�䁥滩𨯙��琜蕭�迚�𨯙��辷蕭
��躰�肽𨯙��躰郭�𨺗��躰�肽𨯙
��躰�肽𨯙��躰�肽𨯙嚙踝蕭隤抵���嚙賬答�𨯙��躰�肽𨯙
安克(4188)
月營收
季盈餘
2025/03/01
16.55元 (安克股價)
2025/03/01
-1.60%
(年增率)
2百萬元 (營收)
安克(4188) 年度營收走勢圖
12
7百萬/月 (110年)
5百萬/月 (111年)
10百萬/月 (112年)
7百萬/月 (113年)
N/A百萬/月 (114年)
安克(4188)月營收明細
單位：仟元
年/月
營收
月增率
去年同期
年增率
累計營收
年增率
114/03
2,209
-2.60%
2,245
-1.60%
6,781
-16.05%
114/02
2,268
-1.56%
3,488
-34.98%
4,572
-21.60%
114/01
2,304
-70.54%
2,344
-1.71%
2,304
-1.71%
113/12
7,821
13.13%
10,251
-23.71%
53,105
-18.62%
113/11
6,913
102.97%
5,051
36.86%
45,284
-17.67%
113/10
3,406
-0.79%
8,108
-57.99%
38,371
-23.18%
113/09
3,433
36.18%
6,877
-50.08%
34,965
-16.44%
113/08
2,521
-44.75%
3,724
-32.30%
31,532
-9.82%
113/07
4,563
-24.13%
5,104
-10.60%
29,011
-7.14%
113/06
6,014
-18.07%
4,617
30.26%
24,448
-6.46%
113/05
7,340
143.29%
6,046
21.40%
18,434
-14.34%
113/04
3,017
34.39%
4,949
-39.04%
11,094
-28.31%
113/03
2,245
-35.64%
4,593
-51.12%
8,077
-23.26%
113/02
3,488
48.81%
3,086
13.03%
5,832
-1.69%
113/01
2,344
-77.13%
2,846
-17.64%
2,344
-17.64%
112/12
10,251
102.95%
5,083
101.67%
65,252
5.88%
112/11
5,051
-37.70%
4,811
4.99%
55,001
-2.73%
112/10
8,108
17.90%
3,898
108.00%
49,950
-3.45%
112/09
6,877
84.67%
4,474
53.71%
41,842
-12.53%
112/08
3,724
-27.04%
4,408
-15.52%
34,965
-19.37%
112/07
5,104
10.55%
4,375
16.66%
31,241
-19.80%
112/06
4,617
-23.64%
6,090
-24.19%
26,137
-24.42%
112/05
6,046
22.17%
4,770
26.75%
21,520
-24.46%
112/04
4,949
7.75%
6,490
-23.74%
15,474
-34.76%
112/03
4,593
48.83%
5,897
-22.11%
10,525
-38.91%
112/02
3,086
8.43%
5,214
-40.81%
5,932
-47.66%
112/01
2,846
-44.01%
6,119
-53.49%
2,846
-53.49%
111/12
5,083
5.65%
7,318
-30.54%
61,629
-28.18%
111/11
4,811
23.42%
5,491
-12.38%
56,546
-27.96%
111/10
3,898
-12.87%
14,062
-72.28%
51,735
-29.13%
111/09
4,474
1.50%
4,764
-6.09%
47,837
-18.83%
111/08
4,408
0.75%
13,480
-67.30%
43,363
-19.95%
111/07
4,375
-28.16%
9,000
-51.39%
38,955
-4.27%
111/06
6,090
27.67%
8,500
-28.35%
34,580
9.11%
111/05
4,770
-26.50%
5,811
-17.91%
28,490
22.84%
111/04
6,490
10.06%
5,657
14.73%
23,720
36.46%
111/03
5,897
13.10%
4,342
35.81%
17,230
46.95%
111/02
5,214
-14.79%
11,333
111/01
6,119
-16.38%
6,119
110/12
7,318
33.27%
85,808
110/11
5,491
-60.95%
78,490
110/10
14,062
195.17%
72,999
110/09
4,764
-64.66%
58,937
110/08
13,480
49.78%
54,173
110/07
9,000
5.88%
40,693
110/06
8,500
46.27%
31,693
110/05
5,811
2.72%
23,193
110/04
5,657
30.29%
17,382
說明：自2013年起上市櫃公司因IFRSs會計準則規範，每月公告的營收必須是合併營收，不再公告非合併營收。2012年(含)前，合併營收是採自願公告。
